Abstract
In their letter regarding my editorial1, Drs Virmani, Wilson, and Finn highlight the parallels between inflammation in pig coronary arteries treated with sirolimus-eluting stents and human coronary arteries in which thrombosis has occurred in relation to the same stent platform. Clearly, inflammation may occur in some human arteries treated with sirolimus-eluting stents. In cases where inflammation is severe, perhaps due to a rare hypersensitivity reaction, the treated …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
